Lipocine Long Term Debt 2012-2025 | LPCN

Lipocine long term debt from 2012 to 2025. Long term debt can be defined as the sum of all long term debt fields.

Lipocine Long Term Debt 2012-2025 | LPCN

Lipocine long term debt from 2012 to 2025. Long term debt can be defined as the sum of all long term debt fields.
Related Stocks
Company NameMarket
Cap
Chugai Pharmaceutical (CHGCY)$77.5B
Zoetis (ZTS)$65.6B
Daiichi Sankyo, - (DSNKY)$46.1B
Takeda Pharmaceutical (TAK)$45.9B
BeOne Medicines - (ONC)$32B
Sandoz Group AG (SDZNY)$25.2B
Summit Therapeutics (SMMT)$19.6B
Merck (MKKGY)$16.6B
Shionogi (SGIOY)$14.4B
United Therapeutics (UTHR)$13.2B
Neurocrine Biosciences (NBIX)$13B
Orion OYJ (ORINY)$11B
IPSEN (IPSEY)$10.5B
Corcept Therapeutics (CORT)$7.4B
Madrigal Pharmaceuticals (MDGL)$7.3B
Stevanato Group S.p.A (STVN)$7.3B
Grifols, S.A (GRFS)$6.9B
Ionis Pharmaceuticals (IONS)$6.6B
Hikma Pharmaceuticals Plc (HKMPF)$6.2B
Ono Pharmaceutical (OPHLF)$5.2B
Soleno Therapeutics (SLNO)$4.4B
Procaps Group, S.A (PROCF)$3.2B
Hypermarcas (HYPMY)$3B
Crinetics Pharmaceuticals (CRNX)$2.9B
Catalyst Pharmaceuticals (CPRX)$2.6B
NewAmsterdam Pharma (NAMS)$2.5B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.5B
Centessa Pharmaceuticals (CNTA)$2.1B
Ocular Therapeutix (OCUL)$1.8B
BioCryst Pharmaceuticals (BCRX)$1.8B